Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_assertion description "[Different studies have already shown that the isolated inactivation of p21, p16, or p27 cyclin-dependent kinase inhibitors (CKIs) is associated with increased growth fraction, tumor progression, or decreased overall survival in cases of non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_assertion evidence source_evidence_literature NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_assertion SIO_000772 11438467 NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_assertion wasDerivedFrom befree-20150227 NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_assertion wasGeneratedBy ECO_0000203 NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP611942.RAjGNix06SRwpjKPPBfYK-56_LLx_PcxVroT60XckZFW4130_provenance.